COVID-19, virus not identified. COVID-19, virus not identified
Conditions
Interventions
Intervention 1: Intervention group:In addition to the drugs prescribed according to the national protocol, Receiving Ivermectin, 6 mg twice daily on the first day and 3 mg twice daily on the second to
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Covid PCR test 19 positive Intubated patient No increase in liver enzymes
Exclusion criteria
Exclusion criteria: History of drug allergy Pregnant Women Withdrawal of the patient's family from continuing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality rate. Timepoint: 30 days range, Daily from the time the patient enters the study. Method of measurement: Vital sign check in 30 days range. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intubation period. Timepoint: in 30 day range, Daily from the time the patient enters the study. Method of measurement: Visual Observation.;Lung Compliance. Timepoint: Daily from the time the patient enters the study. Method of measurement: Calculated based on ventilator data. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Baghbanian
Ahvaz University of Medical Sciences
Outcome results
None listed